Electra Therapeutics, Inc. (ETRA)
NASDAQ: ETRA · Real-Time Price · USD
7.71
-0.36 (-4.46%)
Nov 4, 2026, 1:58 PM EST - Market open
Electra Therapeutics Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Electra Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $33.2. The average 1-year stock price forecast is 330.61% higher than the current stock price, while the lowest is $30 (+289.11%) and the highest is $36 (+366.93%).
Price Target: $33.2 (+330.61%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Electra Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Initiates $30 | Buy | Initiates | $30 | +289.11% | Oct 26, 2026 |
| Jefferies | Jefferies | Buy Initiates $32 | Buy | Initiates | $32 | +315.05% | Oct 13, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Oct 13, 2026 |
| Evercore ISI | Evercore ISI | Buy Initiates $36 | Buy | Initiates | $36 | +366.93% | Oct 13, 2026 |
| TD Cowen | TD Cowen | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Oct 13, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-6.27
EPS Next Year
-1.80
from -6.27
EPS and Forward PE are based on non-GAAP adjusted numbers.